相关实验视频
Updated: Jun 16, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
E2F7上调MCM4和脂肪酸代谢,促进肺腺癌转移
WuAsen Tang1, Deming Zhang1, Di Liu1
1Department of Cardiothoracic and Macrovascular Surgery, Jingzhou Hospital Affiliated to Yangtze University, No.26 Chuyuan Avenue, Jingzhou District, Jingzhou City, Hubei province 434020, China.
过度表达的MCM4通过激活脂肪酸代谢驱动肺腺癌 (LUAD) 转移. 针对由E2F7调节的这种途径,为LUAD治疗提供了新的治疗策略.
科学领域:
- 分子瘤学分子瘤学
- 癌症转移 癌症转移
- 脂质代谢 脂质代谢是什么
背景情况:
- 在各种癌症中MCM4过度表达,但其在肺腺癌 (LUAD) 转移中的作用仍未确定.
- 了解LUAD转移的分子驱动因素对于开发有效治疗方法至关重要.
研究的目的:
- 研究MCM4在LUAD转移中的特定作用.
- 阐明潜在的分子机制,包括E2F7和脂肪酸代谢的参与.
主要方法:
- 在LUAD中对MCM4和E2F7表达的生物信息分析.
- 使用qRT-PCR,Western Blot,细胞计数试验,Transwell试验和脂质量测试进行实验验证.
- 染色体免疫沉降和双化酶记者测定证实了E2F7对MCM4.4的转录调节.
主要成果:
- 过度表达MCM4与增加的LUAD细胞增殖,迁移,入侵和转移有关.
- 击败MCM4减少了这些转移性表型,并降低了脂肪酸合成酶 (FASN) 表达和脂质水平.
- E2F7被确定为MCM4的转录激活剂,在LUAD进展中将E2F7,MCM4和脂肪酸代谢联系起来.
结论:
- E2F7通过转录上调MCM4,促进脂肪酸代谢和驱动LUAD转移.
- 脂质代谢在LUAD的发展和进展中起着至关重要的作用.
- E2F7-MCM4轴代表了LUAD的潜在治疗目标.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
10:26Assessment of Mitochondrial Health in Cancer-Associated Fibroblasts Isolated from 3D Multicellular Lung Tumor Spheroids
Published on: October 21, 2022
相关概念视频
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
The Tumor Microenvironment
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Master Transcription Regulators
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...